(CDAK) – FDA
-
Codiak BioSciences (CDAK) Reports Platform-Validating Clinical Update and Data from Phase 1 Trials of exoSTING and exoIL-12
-
Codiak BioSciences (CDAK) Reports Preclinical Data Supporting Development of a Broadly Protective Pan Beta-Coronavirus Vaccine
-
-
-
-
-
-
-
Back to CDAK Stock Lookup